Lazar Mandinov
Corporate Officer/Principal bij The European Society of Cardiology
Profiel
Lazar Mandinov is a member of The European Society of Cardiology.
He previously worked as a Medical Director at Boston Scientific Corp., Chief Medical Officer at Mitralign, Inc., and Principal at Maine Medical Center Research.
Dr. Mandinov holds a doctorate degree from Medical University Sofia.
Actieve functies van Lazar Mandinov
| Bedrijven | Functie | Begin |
|---|---|---|
| The European Society of Cardiology | Corporate Officer/Principal | - |
Eerdere bekende functies van Lazar Mandinov
| Bedrijven | Functie | Einde |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Hoofd Techniek/Wetenschap/O&O | - |
| Maine Medical Center Research | Corporate Officer/Principal | - |
Mitralign, Inc.
 Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Lazar Mandinov
| Medical University Sofia | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Mitralign, Inc.
Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA. | Health Technology |
| The European Society of Cardiology | |
| Maine Medical Center Research |
